| __timestamp | Sanofi | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 21769000000 | 519428000 |
| Thursday, January 1, 2015 | 23942000000 | 906794000 |
| Friday, January 1, 2016 | 23995000000 | 1491717000 |
| Sunday, January 1, 2017 | 24774000000 | 2213533000 |
| Monday, January 1, 2018 | 24356000000 | 2638058000 |
| Tuesday, January 1, 2019 | 25655000000 | 3615063000 |
| Wednesday, January 1, 2020 | 25212000000 | 5469383000 |
| Friday, January 1, 2021 | 26920000000 | 6670200000 |
| Saturday, January 1, 2022 | 31697000000 | 7850400000 |
| Sunday, January 1, 2023 | 31797000000 | 8607000000 |
| Monday, January 1, 2024 | 9489600000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical industry, the financial performance of companies like Sanofi and Vertex Pharmaceuticals Incorporated offers a fascinating glimpse into their strategic prowess. Over the past decade, Sanofi has consistently outperformed Vertex in terms of gross profit, with an average of approximately $26 billion annually. In contrast, Vertex has shown remarkable growth, increasing its gross profit by over 1,500% from 2014 to 2023, reaching nearly $8.6 billion.
Sanofi's steady growth, peaking at $31.8 billion in 2023, underscores its established market presence. Meanwhile, Vertex's rapid ascent highlights its innovative breakthroughs, particularly in niche markets. This financial narrative not only reflects the companies' operational strategies but also the broader trends in the pharmaceutical sector, where innovation and market expansion are key drivers of success.
Gross Profit Trends Compared: Johnson & Johnson vs Vertex Pharmaceuticals Incorporated
Revenue Showdown: Sanofi vs Vertex Pharmaceuticals Incorporated
Gross Profit Trends Compared: Sanofi vs Halozyme Therapeutics, Inc.
Sanofi vs Corcept Therapeutics Incorporated: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing Sanofi and HUTCHMED (China) Limited
Sanofi vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing Sanofi and Amphastar Pharmaceuticals, Inc.
Gross Profit Comparison: Sanofi and Taro Pharmaceutical Industries Ltd. Trends
Gross Profit Analysis: Comparing Gilead Sciences, Inc. and Vertex Pharmaceuticals Incorporated
Gross Profit Analysis: Comparing Vertex Pharmaceuticals Incorporated and Jazz Pharmaceuticals plc
Gross Profit Analysis: Comparing Vertex Pharmaceuticals Incorporated and Arrowhead Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated vs Evotec SE: A Gross Profit Performance Breakdown